You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Conjugation
Biologically Active
Featured Product
Search results for: 'IL-31'
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 82.03 KDa. Observed: 132 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 57.5 KDa. Observed: 90-130 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Featured
Active
Item 1 of 1FeaturedActive> 97% as determined by SDS-PAGE and HPLC.
15.8 kDa
E.Coli
10 μg, 100 μg, 500 μg - Item 1 of 3
ELISA, SDS-PAGE, WB
>90% as determined by SDS-PAGE.
18.27 kDa
1 mg, 50 μg, 100 μg - FeaturedItem 1 of 2Featured
Unconjugated
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
The protein has a predicted molecular mass of 42 kDa after removal of the signal peptide. The apparent molecular mass of IL31-hFc is approximately 35-55 kDa due to glycosylation.
Mammalian
10 μg, 50 μg, 100 μg - ActiveItem 1 of 1Active
Unconjugated
95%
83.5 kDa
1 mg, 100 μg - ActiveItem 1 of 1Active
Unconjugated
95%
59.0 kDa
100 μg, 1 mg ELISA, SDS-PAGE, WB
>95% as determined by SDS-PAGE.
85.18 kDa
1 mg, 50 μg, 100 μgELISA, SDS-PAGE, WB
>90% as determined by SDS-PAGE.
38.84 kDa
1 mg, 50 μg, 100 μgELISA, SDS-PAGE, WB
>95% as determined by SDS-PAGE.
109.08 kDa
1 mg, 50 μg, 100 μg
